This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Responses to Growth Factors

Vito C. Quatela, MD; David A. Sherris, MD; Randy N. Rosier, MD, PhD

Arch Otolaryngol Head Neck Surg. 1993;119(1):32-37.

Abstract
• The first human auricular (elastic cartilage) chondrocyte cell culture model is presented. These chondrocytes, harvested from fresh human cadaver auricular cartilage, are easily grown in culture. They produce type II collagen and abundant alkaline phosphatase. Like growth plate chondrocytes, human auricular chondrocytes respond mitogenically to both transforming growth factor-β and basic fibroblast growth factor by increasing proliferation twofold. The growth factors exert a synergistic effect on thymidine uptake in this model, with maximal stimulation occurring at the dose combination of basic fibroblast growth factor, 10 ng/mL, and transforming growth factor-β, 3 ng/mL. Human nasal septal (hyaline cartilage) chondrocytes do not increase proliferation in response to these two growth factors. Human auricular chondrocytes also increase matrix production in response to transforming growth factor-β, as indicated by increased proteoglycan production and increased collagen synthesis. The increased matrix production combined with increased proliferative rate elicited with transforming growth factor-β and basic fibroblast growth factor indicates that human elastic cartilage chondrocytes harvested from the external ear are better suited for in vitro cartilage implant growth than human hyaline cartilage chondrocytes. Further biochemical and molecular biological characterization of the human auricular chondrocyte cell culture model is currently under way. Additional work is also under way to generate multilayer culture growth on absorbable frameworks, in the pursuit of the long-term goal of in vitro production of autogenous cartilage implants.

(Arch Otolaryngol Head Neck Surg. 1993;119:32-37)

Author Affiliations
From the Division of Otolaryngology—Head and Neck Surgery (Drs Quatela and Sherris) and the Department of Orthopaedics (Dr Rosier), University of Rochester (NY) Medical Center.

Footnotes
Accepted for publication August 3, 1992.

Presented at the American Academy of Facial Plastic and Reconstructive Surgery, Eastern and Canadian Regional Meeting, New York, NY, January 11, 1992.

Reprint requests to Division of Otolaryngology—Head and Neck Surgery, University of Rochester Medical Center, 601 Elmwood Ave, Box 8629, Rochester, NY 14642-8629 (Dr Sherris).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Autologous Cartilage Grafts Enhanced by a Novel Transplant Medium Using Fibrin Sealant and Fibroblast Growth Factor
Kaufman et al.
Arch Facial Plast Surg 2004;6:94-100.
ABSTRACT | FULL TEXT  

Influence of Growth Factors on Tissue-Engineered Pediatric Elastic Cartilage
Arevalo-Silva et al.
Arch Otolaryngol Head Neck Surg 2000;126:1234-1238.
ABSTRACT | FULL TEXT  

Basic Fibroblast Growth Factor and Insulinlike Growth Factor I Support the Growth of Human Septal Chondrocytes in a Serum-Free Environment
Dunham and Koch
Arch Otolaryngol Head Neck Surg 1998;124:1325-1330.
ABSTRACT | FULL TEXT